Drug Approval | July 05, 2023
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
For the treatment of Superficial Femoral Artery
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Subscribe To Our Newsletter & Stay Updated
